GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (STU:UDJ) » Definitions » EV-to-Revenue

Applied DNA Sciences (STU:UDJ) EV-to-Revenue : 0.14 (As of May. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Applied DNA Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Applied DNA Sciences's enterprise value is €1.19 Mil. Applied DNA Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €8.36 Mil. Therefore, Applied DNA Sciences's EV-to-Revenue for today is 0.14.

The historical rank and industry rank for Applied DNA Sciences's EV-to-Revenue or its related term are showing as below:

STU:UDJ' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.13   Med: 8.05   Max: 100.12
Current: 0.14

During the past 13 years, the highest EV-to-Revenue of Applied DNA Sciences was 100.12. The lowest was -0.13. And the median was 8.05.

STU:UDJ's EV-to-Revenue is ranked better than
94.25% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.08 vs STU:UDJ: 0.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-03), Applied DNA Sciences's stock price is €4.33. Applied DNA Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €12.83. Therefore, Applied DNA Sciences's PS Ratio for today is 0.34.


Applied DNA Sciences EV-to-Revenue Historical Data

The historical data trend for Applied DNA Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences EV-to-Revenue Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 17.76 3.74 -0.03 0.79

Applied DNA Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.21 0.45 0.79 0.68

Competitive Comparison of Applied DNA Sciences's EV-to-Revenue

For the Diagnostics & Research subindustry, Applied DNA Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's EV-to-Revenue falls into.



Applied DNA Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Applied DNA Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.190/8.357
=0.14

Applied DNA Sciences's current Enterprise Value is €1.19 Mil.
Applied DNA Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences  (STU:UDJ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Applied DNA Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.33/12.828
=0.34

Applied DNA Sciences's share price for today is €4.33.
Applied DNA Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €12.83.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (STU:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (STU:UDJ) Headlines

No Headlines